Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

New Potential Breast Cancer Treatment

Triple-negative breast cancer is the most aggressive and lethal form of cancer due to lack of treatment options and high recurrence rates. The estrogen, progesterone, and human epidermal growth factor receptor 2 (HER2) are not expressed in these tumors. They are able to grow and spread faster than other types of cancer, therefore limiting treatment by chemotherapy. There are currently no targeted therapies developed for triple negative resurfacing at this time. We have previously reported on what we know about breast cancer biomarkers and targeting epigenetic proteins to prevent breast cancer.

In a recent study, researchers have identified estradiol as a new potential treatment for a subset of women with triple-negative breast cancer. The naturally occurring female hormone estradiol normally stimulates tumor expressing estrogen receptor alpha. Estrogen beta receptor has been shown to be present in 25% of triple-negative tumors and over 30% in estrogen receptor-positive tumors. Interestingly, estradiol inhibits the growth of triple-negative breast cancer tumors expressing estrogen receptor beta. Estradiol can bind to estrogen receptor beta and induce the secretion of cystatins that can inhibit tumor growth. Therefore, these findings suggest that estrogen receptor beta-targeted therapies could be a treatment option for the subset of women with estrogen receptor beta-expressing triple-negative breast cancer. Further clinical testing is needed to test the effectiveness against triple-negative cancer.

For more information: http://www.pnas.org/content/early/2018/09/25/1807751115

Enzo Life Sciences provides a wide range of products for all your Cancer research needs. We offer a highly sensitive 17β-Estradiol high sensitivity ELISA kit detecting as little as 14pg/ml of 17β-estradiol. Our HER2/Neu monoclonal antibody provides a cost-effective opportunity for strong, clear staining with minimal background. Enzo’s immunohistochemistry reagents provide a complete set of tools for an efficient IHC process from start to finish. Our SCREEN-WELL® Cancer Library provides a unique collection of 275 compounds. Furthermore, our FISH reagents provide everything you need for labeling, hybridization, and detection.

Never miss a new TechNote!

Receive our TechNotes as soon as they are published.


 
comments powered by Disqus

Follow Us!

 

Related Products

Estriol ELISA kit 

Certified for a large variety of sample types for steroid and hormone research.
ELISA, Colorimetric detection | Print as PDF
 
ADI-900-100 96 wells 347.00 USD
Do you need bulk/larger quantities?
 

17β-Estradiol high sensitivity ELISA kit 

Highly sensitive ELISA, detecting as little as 14 pg/ml of 17β-Estradiol
ELISA, Colorimetric detection | Print as PDF
 
ADI-900-174 96 wells 398.00 USD
Do you need bulk/larger quantities?
 

17β-Estradiol high sensitivity ELISA kit 

Highly sensitive ELISA, detecting as little as 14 pg/ml of 17β-Estradiol
ELISA, Colorimetric detection | Print as PDF
 
ADI-901-174 5x96 wells 1,596.00 USD
Do you need bulk/larger quantities?
 

HER2/Neu monoclonal antibody 

Monoclonal antibody to HER2 for use with IHC applications
IHC | Print as PDF
 
ENZ-ABS381-0100 100 µl 448.00 USD
 
ENZ-ABS381-1000 1 ml 2,533.00 USD
Do you need bulk/larger quantities?
 

SCREEN-WELL® Cancer Library 

Essential standards for cancer inhibitor screening
HTS | Print as PDF
 
ENZ-LIB102-0100 1 Library 100 µl/well 6,574.00 USD
Do you need bulk/larger quantities?
 

Estrogen receptor monoclonal antibody (h-151) 

Purified from mouse ascites., ICC, IP, WB | Print as PDF
 
ADI-SRA-1000-D 50 µg 225.00 USD
 
ADI-SRA-1000-F 200 µg 501.00 USD
Do you need bulk/larger quantities?
 

Estrogen receptor α monoclonal antibody (33) 

Flow Cytometry, ICC, IF, IHC (FS), IHC (PS), IP, WB | Print as PDF
 
ALX-803-004-C050 50 µg 744.00 USD
Do you need bulk/larger quantities?
 

Progesterone ELISA kit 

Highly specific and sensitive ELISA kit with results in < 3h
ELISA, Colorimetric detection | Print as PDF
 
ADI-900-011 96 wells 368.00 USD
Do you need bulk/larger quantities?
 

SCREEN-WELL® FDA approved drug library V2 

Accelerates drug optimization with a unique collection of compounds of known safety and bioavailability for diverse targets.
HTS | Print as PDF
 
BML-2843-0100 1 Library 100 µl/well 10,114.00 USD
Do you need bulk/larger quantities?
 

PD-1 (human), (recombinant) 

Produced in HEK cells. Extracellular domain of PD-1 (aa 25-167) containing a 5’-His-tag, V5 epitope tag spacer, and a FLAG-tag., ≥90% (SDS-PAGE) | Print as PDF
 
ENZ-PRT190-0050 50 µg 395.00 USD
Do you need bulk/larger quantities?
 

PD-L1 (human), (recombinant) 

Produced in HEK cells. Human PD-L1 (aa 19-239) is fused at the N-terminus to a His-tag and FLAG®-tag., ≥90% (SDS-PAGE) | Print as PDF
 
ENZ-PRT223-0100 100 µg 619.00 USD
Do you need bulk/larger quantities?
 

Recommend this page